Skip to main content
AIMV
OTC Technology

AI Maverick Intel Signs Definitive Deal to Acquire HEAL Access, Pivots to AI Healthcare

Tom Rudovsky · Reported by Wiseek News
More coverage: Technology
Sentiment info
Positive
Importance info
7
Price
$0.15
Mkt Cap
$7.313M
52W Low
$0.012
52W High
$0.448
52W Position info
1150% above low
Off High info
67% below high
Rel. Volume
Market data snapshot near publication time

AIMV has more than doubled off its 52-week low of $0.012.

Summary

AI Maverick Intel signed a definitive agreement to acquire 100% of HEAL Access Canada Inc., marking a strategic pivot into AI-enabled healthcare. The deal is subject to financing and other closing conditions, so completion is not assured. The company also appointed Dr. Wayne Young to its board, adding healthcare expertise, and mutually rescinded its August 2024 Stronghold Media transaction, which reverts prior IP and alters the asset mix. A planned corporate name change signals repositioning. For a micro-cap with a $7.3M market cap, this is a material strategic shift, though financing risk remains the key hurdle.

At the time of this announcement, AIMV was trading at $0.15 on OTC in the Technology sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.01 to $0.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AIMV - Latest Insights